Ciqtek Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ciqtek and similar public comparables like INFICON, Renishaw, Itron, Badger Meter and more.

Ciqtek Overview

About Ciqtek

Ciqtek Co Ltd is engaged in the research, development, production and sales of high-end scientific instruments. Its main business includes Electron Microscopy (FIB/SEM, TEM), Nuclear Magnetic Resonance (NMR) Spectroscopy, Electron Paramagnetic Resonance (EPR/ESR) Spectroscopy, and BET Surface Area & Pore Analyzers. The company provides customized products and solutions across environmental science, biochemistry, semiconductor technology, and materials science.


Founded

2016

HQ

China

Employees

N/A

Financials (FY)

Revenue: $99M
EBITDA: $6M

EV

$4.8B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ciqtek Financials

Ciqtek reported last fiscal year revenue of $99M and EBITDA of $6M.

In the same fiscal year, Ciqtek generated $46M in gross profit, $6M in EBITDA, and had net loss of ($860K).


Ciqtek P&L

In the most recent fiscal year, Ciqtek reported revenue of $99M and EBITDA of $6M.

Ciqtek is unprofitable as of last fiscal year, with gross margin of 47%, EBITDA margin of 6%, and net margin of (1%).

See analyst estimates for Ciqtek
Last FY202320242025202620272028
Revenue$99M$59M$74M$99M
Gross Profit$46M$20M$30M$46M
Gross Margin47%33%40%47%
EBITDA$6M($17M)($8M)$6M
EBITDA Margin6%(29%)(10%)6%
EBIT Margin0%(35%)(13%)0%
Net Profit($860K)($21M)($11M)($860K)
Net Margin(1%)(35%)(15%)(1%)
Net Debt$6M---

Financial data powered by Morningstar, Inc.

Ciqtek Stock Performance

Ciqtek has current market cap of $4.7B, and enterprise value of $4.8B.


Ciqtek's stock price is $11.79.

See more trading valuation data for Ciqtek
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4.8B$4.7B-18.2%---$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ciqtek Valuation Multiples

Ciqtek trades at 48.1x EV/Revenue multiple, and 808.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Ciqtek

Ciqtek Financial Valuation Multiples

As of August 20, 2026, Ciqtek has market cap of $4.7B and EV of $4.8B.

Ciqtek has a P/E ratio of (5480.0x).

Last FY202320242025202620272028
EV/Revenue48.1x80.2x63.9x48.1x
EV/EBITDAn/mn/mn/mn/m
EV/EBITn/m(229.7x)n/mn/m
EV/Gross Profit102.5x240.6x158.2x102.5x
P/En/m(226.9x)n/mn/m
EV/FCFn/m(115.5x)(168.3x)n/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ciqtek Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ciqtek Margins & Growth Rates

In the most recent fiscal year, Ciqtek reported gross margin of 47%, EBITDA margin of 6%, and net margin of (1%).

See estimated margins and future growth rates for Ciqtek

Ciqtek Margins

Last FY20242025202720282029
Gross Margin47%40%47%
EBITDA Margin6%(10%)6%
EBIT Margin0%(13%)0%
Net Margin(1%)(15%)(1%)
FCF Margin11%(38%)11%

Ciqtek Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth25%33%
Gross Profit Growth52%54%
EBITDA Growth(54%)(176%)
EBIT Growth(55%)(105%)
Net Profit Growth(47%)(92%)
FCF Growth(31%)(139%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Ciqtek Operational KPIs

Access forward-looking KPIs for Ciqtek
Last FY202320242025202620272028
S&M Expenses to Revenue7%7%7%7%
G&A Expenses to Revenue5%9%9%5%
R&D Expenses to Revenue17%33%23%17%
Opex to Revenue46%68%53%46%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ciqtek Competitors

Ciqtek competitors include INFICON, Renishaw, Itron, Badger Meter, Comet Holding, Horiba, CHCNav, Sensata Technologies, Raycus Laser and Anritsu.

Most Ciqtek public comparables operate across Test & Measurement.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
INFICON7.1x6.4x38.0x29.5x
Renishaw4.9x4.3x24.4x18.6x
Itron2.2x2.2x14.2x13.5x
Badger Meter4.0x4.1x17.0x17.4x
Comet Holding6.0x5.1x66.3x35.1x
Horiba2.6x2.4x13.7x10.8x
CHCNav5.6x5.1x23.0x22.1x
Sensata Technologies2.2x2.2x16.2x9.4x

This data is available for Pro users. Sign up to see all Ciqtek competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ciqtek

When was Ciqtek founded?Ciqtek was founded in 2016.
Where is Ciqtek headquartered?Ciqtek is headquartered in China.
Is Ciqtek publicly listed?Yes, Ciqtek is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of Ciqtek?Ciqtek trades under 688828 ticker.
When did Ciqtek go public?Ciqtek went public in 2026.
Who are competitors of Ciqtek?Ciqtek main competitors include INFICON, Renishaw, Itron, Badger Meter, Comet Holding, Horiba, CHCNav, Sensata Technologies, Raycus Laser, Anritsu.
What is the current market cap of Ciqtek?Ciqtek's current market cap is $4.7B.
What is the current revenue of Ciqtek?Ciqtek's last fiscal year revenue is $99M.
What is the current EV/Revenue multiple of Ciqtek?Current revenue multiple of Ciqtek is 48.1x.
Is Ciqtek profitable?No, Ciqtek is not profitable.
How many companies Ciqtek has acquired to date?Ciqtek hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Ciqtek has invested to date?Ciqtek hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Ciqtek

Lists including Ciqtek

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial